Jeevan Scientific Technology Limited

BSE: JSTL538837ISIN INE237B01018

Healthcare
Healthcare Research, Analytics & Technology

BSE listing

Share price

₹81.25+0.59 (+0.73%)

as of 18 Sep 2026

52W high: ₹93.90
52W low: ₹32.85
Off 52W high: -13.47%
1M return: +9.43%
3M return: +1.51%
6M return: +22.83%
1Y return: +107.75%
20D avg volume: 20,469
50 DMA: ₹75.60
200 DMA: ₹72.30

Key ratios Consolidated

Market cap: ₹163.15 Cr
Current price: ₹81.25
52W high / low: ₹93.90 / ₹32.85
Face value: ₹10.00
P/E: 31.59
P/B: —
EPS (TTM): ₹2.57
Book value / share: —
ROE: —
ROCE: 4.80%
Operating margin: —
Net margin: —
Debt / equity: 0.24
Net debt: ₹7.65 Cr
Interest cover: 2.02
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 104.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	18.28	21.29	19.07	12.38	8.80	10.06	—
	0.17	0.29	0.14	0.20	0.33	0.15	—
	17.47	19.00	15.99	12.55	12.86	12.76	—
	1.71	1.62	1.49	1.00	0.77	1.15	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	5.74	5.97	5.55	5.10	5.02	4.99	—
	0.44	0.41	0.54	0.55	0.54	0.55	—
	1.70	1.61	1.60	1.69	1.74	1.77	—
	7.87	9.39	6.81	4.21	4.79	4.30	—
	0.98	2.58	3.23	0.03	-3.73	-2.55	—
	0.00	-0.02	0.00	0.00	0.00	0.00	—
	0.98	2.56	3.23	0.03	-3.73	-2.55	—
	0.11	0.72	0.83	0.02	-0.51	-1.29	—
	0.87	1.84	2.40	0.01	-3.22	-1.26	—
	0.44	0.92	1.52	0.01	-2.03	-0.81	—
Key metrics
	3.12	4.58	5.37	2.27	-1.45	-0.23	—
	17.10%	21.50%	28.20%	18.30%	-16.50%	-2.30%	—
	4.80%	8.60%	12.60%	0.10%	-36.60%	-12.50%	—
	—	3.40%	—	1.00%	—	-3.00%	—
	107.70%	111.60%	—	—	—	—	—
	127.00%	246.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	71.02	61.54	46.84	—
	0.80	0.97	0.65	—
	65.01	60.40	47.45	—
	5.82	4.88	3.80	—
	0.00	0.00	0.00	—
	22.36	21.64	17.06	—
	1.94	2.04	1.76	—
	6.60	6.64	6.25	—
	28.28	25.20	18.57	—
	6.82	2.11	0.05	—
	-0.02	-0.02	0.00	—
	6.80	2.09	0.05	—
	1.68	1.06	-0.01	—
	5.12	1.03	0.06	—
	2.89	0.52	0.04	—
Key metrics
	15.34	10.77	8.06	—
	21.60%	17.50%	17.20%	—
	7.21%	1.70%	0.10%	—
	—	4.80%	2.70%	—
	—	31.40%	—	—
	—	1,616.70%	—	—
	—	-7.76	-5.96	—
	—	0.41	167.83	—
	—	0.24	0.30	—
	—	7.65	14.90	—
	—	104.3	112.0	—
Balance sheet
	—	106.59	78.29	—
	—	49.87	28.76	—
	—	9.51	0.24	—
	—	20.69	15.94	—
	—	3.03	1.62	—
	—	8.26	5.97	—
	—	25.44	22.70	—
	—	6.13	3.18	—
	—	19.89	12.07	—
	—	17.16	15.14	—
	—	7.06	3.41	—
	—	10.10	11.73	—
	—	72.95	50.07	—
Cash flow
	—	0.42	10.07	—
	—	-9.98	-15.62	—
	—	18.83	5.24	—
	—	8.18	16.03	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	16.93	18.38	16.91	10.43	8.22	8.92	—
	0.26	0.37	0.18	0.26	0.38	0.14	—
	15.02	16.51	13.99	10.79	11.19	11.72	—
	1.58	1.49	1.38	0.94	0.62	1.12	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	4.95	4.95	4.57	4.26	4.21	4.61	—
	0.30	0.25	0.38	0.38	0.36	0.35	—
	1.43	1.36	1.35	1.45	1.50	1.53	—
	6.77	8.46	6.31	3.77	4.49	4.10	—
	2.18	2.23	3.10	-0.09	-2.59	-2.65	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	2.18	2.23	3.10	-0.09	-2.59	-2.65	—
	0.29	0.63	0.80	-0.01	-0.43	-1.31	—
	1.89	1.59	2.30	-0.09	-2.16	-1.34	—
	0.95	0.80	1.45	-0.05	-1.36	-0.86	—
Key metrics
	3.91	3.84	4.83	1.74	-0.73	-0.77	—
	23.10%	20.90%	28.60%	16.70%	-8.90%	-8.60%	—
	11.20%	8.70%	13.60%	-0.90%	-26.30%	-15.00%	—
	—	3.00%	—	0.50%	—	-3.70%	—
	106.00%	106.10%	—	—	—	—	—
	187.50%	218.70%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	62.65	53.93	43.61	—
	1.07	1.19	0.63	—
	56.31	52.48	43.47	—
	5.39	4.43	3.65	—
	0.00	0.00	0.00	—
	18.73	17.99	15.65	—
	1.31	1.38	1.04	—
	5.59	5.65	5.29	—
	25.31	23.02	17.84	—
	7.42	2.64	0.77	—
	0.00	0.00	0.00	—
	7.42	2.64	0.77	—
	1.71	0.99	0.03	—
	5.69	1.65	0.74	—
	3.15	0.83	0.47	—
Key metrics
	14.32	9.67	7.10	—
	22.86%	17.90%	16.30%	—
	9.08%	3.10%	1.70%	—
	—	4.80%	2.90%	—
	—	23.70%	—	—
	—	123.00%	—	—
	—	-8.79	-7.34	—
	—	1.55	4.00	—
	—	0.16	0.16	—
	—	2.11	8.03	—
	—	100.8	105.4	—
Balance sheet
	—	99.25	70.62	—
	—	50.57	29.91	—
	—	9.47	0.21	—
	—	18.53	14.39	—
	—	1.61	0.93	—
	—	6.26	4.38	—
	—	20.93	17.57	—
	—	5.24	2.73	—
	—	16.31	8.49	—
	—	11.58	8.24	—
	—	5.23	2.22	—
	—	6.35	6.02	—
	—	73.30	50.92	—
Cash flow
	—	2.56	2.96	—
	—	-13.92	-9.84	—
	—	20.62	6.58	—
	—	11.35	10.30	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 30.23%

Holder	Type	Holding	Previous	Change
KRISHNA KISHORE KUCHIPUDI	Promoter	9.71%	—	—
K VANAJA	Promoter	7.90%	—	—
CHENNAMANENI SUSHMITHA	Public	7.53%	—	—
JEEVAN KRISHNA KUCHIPUDI	Promoter Group	4.61%	—	—
GOPI KRISHNA KILARU	Promoter	3.61%	—	—
DHEERAJ KUMAR LOHIA	Public	2.65%	—	—
RADHIKA RAMPA	Public	2.51%	—	—
SHEELA BANGAD	Public	2.51%	—	—
SHRADHA BANGAD	Public	2.01%	—	—
RAVI THAMMAREDDY	Promoter	1.97%	—	—
PRITY AGARWAL	Public	1.74%	—	—
DURISALA DESAIAH	Public	1.66%	—	—
PRANALI BANGAD	Public	1.51%	—	—
SUSHMA BANGAD	Public	1.51%	—	—
VIDYULLATHA KODALI	Public	1.51%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Newspaper Advertisement -Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.4 Sep 2026 · Company Update / Newspaper Publication
Intimation of Book Closure and Cut- off date for the 28th Annual General Meeting of the Company3 Sep 2026 · AGM/EGM / AGM
28th Annual report3 Sep 2026 · Others / Reg. 34 (1) Annual Report
28th Annual General meeting of the Company is scheduled to be held on 25.09.2026 at 10:00 a.m.3 Sep 2026 · AGM/EGM / AGM
Statement on Deviation or Variation of funds under Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.13 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Announcement under Regulation 30 (LODR)- change in management13 Aug 2026 · Company Update / Change in Management
Unaudited financial results (standalone and consolidated) for the quarter ended 30.06.2026.13 Aug 2026 · Result / Financial Results
Outcome of the Board Meeting held on 13.08.202613 Aug 2026 · Board Meeting / Outcome of Board Meeting
Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Intimation of ....10 Aug 2026 · Board Meeting / Board Meeting
Intimation of Approval for addition of Beds to the Existing Approved Bioavailability/ Bioequivalence Center of Jeevan Scientific Technology Limited''s Bioavailability/ Bioequivalence Study ....1 Aug 2026 · Company Update / General
Information about the Successful Completion of USFDA Inspection at JSTL under Regulation 30 of SEBI (LODR) Regulations, 2015.24 Jul 2026 · Company Update / General
Compliance as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2026.16 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notification of Inspection for additional beds to the Existing Approved Bioavailability/ Bioequivalence center of Jeevan Scientific Technology.25 Jun 2026 · Company Update / General
Closure of Trading Window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Annual Secretarial Compliance Report for the Financial year ended 31st March,2026 as per Regulation 24 A of SEBI (Listing and Disclosure Requirements) Regulations, 2015(''Listing Regulations)29 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Statement of Deviation or Variation of funds under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015.29 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Appointment of M/s. KP & Associates, Chartered Accountants as Internal Auditors of the Company for the FY 2026-2729 May 2026 · Company Update / Change in Management
Audited financial results for the quarter and year ended 31.03.202629 May 2026 · Result / Financial Results
Outcome of Board Meeting held on 29.05.202629 May 2026 · Board Meeting / Outcome of Board Meeting
Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Intimation of ....21 May 2026 · Board Meeting / Board Meeting
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....30 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....30 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Compliance as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31,2026.14 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nageswar Rao Yarlagadda30 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nageswar Rao Yarlagadda30 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015.25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Unaudited Financial Results for the quarter ended 31-12-2025.11 Feb 2026 · Result / Financial Results
Outcome of Board Meeting held on 11-02-202611 Feb 2026 · Others / Outcome without intimation
Disclosure under Regulation 30 of (LODR) Regulations, 201522 Jan 2026 · Company Update / General
Compliances as per Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025.13 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padmaja Private Trust7 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vanaja Kuchipudi, Jeevan Kuchipudi and Krishna Kuchipudi7 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Kishore Kuchipudi6 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jeevan Krishna Kuchipudi6 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vanaja Kuchipudi6 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jeevan Krishna Kuchipudi6 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sushma Bangad, Shradha Bangad, Pranali Bangat, ....6 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shradha Bangad & PACs6 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Board meetings

13 Aug 2026 Board Meeting - Financial Results